0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Superior survival for breast-conserving therapy over mastectomy in patients with breast cancer: A population-based SEER database analysis across 30 years

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          It has been believed that breast-conserving therapy (lumpectomy plus adjuvant radiation, Lum + RT) and mastectomy without radiation (Mast + NoRT) have equivalent survival outcomes. However, there is a need to re-evaluate the role of lumpectomy plus adjuvant radiation due to changed breast cancer management over time. This study aimed to conduct a population-based study that compare long-term oncologic survival outcomes after Lum + RT vs Mast + NoRT.

          Methods

          The Surveillance, Epidemiology and End Results database was used to identify female breast cancer patients with a primary localized breast cancer diagnosis from 1988 to 2018. The standardized incidence/mortality ratio (SIR/SMR) for breast cancer recurrence (BCR) and breast cancer-specific death (BSD) was estimated by the SEER*Stat program. Cumulative incidences of BCR and BSD were assessed using Gray’s method. We evaluated the effects of Lum + RT vs. Mast + NoRT on breast cancer recurrence-free survival (BRFS) and breast cancer-specific survival (BCSS). Fine-Gray competing risk model analyses, propensity score-adjusted Kaplan-Meier analyses and Cox proportional hazards model analyses were applied.

          Results

          A total of 205,788 women were included in the study. Patients who underwent Lum + RT had higher SIR of BCR (4.14 [95% confidence interval, CI: 3.94-4.34] vs. 1.11 [95% CI: 1.07-1.14]) and lower SMR (9.89 [95% CI: 9.71-10.08] vs. 17.07 [95% CI: 16.82-17.33]) than patients who underwent Mast + NoRT. Lum + RT was associated with higher competing risk of BCR (adjusted hazard ratio [HR]: 1.996, 95% CI: 1.925-2.069, p < 0.001) and lower competing risk of BSD when compared to Mast + RT (adjusted HR: 0.584, 95% CI: 0.572-0.597, p < 0.001). Multivariate Cox regression analysis revealed similar results (adjusted HR after PSW for BRFS: 1.792, 95% CI 1.716-1.871, p < 0.001; adjusted HR after PSW for BCSS: 0.706, 95% CI 0.688-0.725, p < 0.001). These findings persisted in the sensitivity and subgroup analyses.

          Discussion

          The present study further confirmed superior long-term survival with lumpectomy plus adjuvant radiation over mastectomy independent of patient characteristics including age, race, time period, historic subtype, tumor size, historic grade and stage, indicating that this benefit may result from the treatment itself.

          Related collections

          Most cited references58

          • Record: found
          • Abstract: not found
          • Article: not found

          A Proportional Hazards Model for the Subdistribution of a Competing Risk

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer

            New England Journal of Medicine, 347(16), 1233-1241
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk

                Bookmark

                Author and article information

                Contributors
                Journal
                Front Oncol
                Front Oncol
                Front. Oncol.
                Frontiers in Oncology
                Frontiers Media S.A.
                2234-943X
                04 January 2023
                2022
                : 12
                : 1032063
                Affiliations
                [1] 1 Department of Oncology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital , Zhengzhou, China
                [2] 2 Department of Radiation Oncology, The First Affiliated Hospital, College of Medicine, Zhejiang University , Hangzhou, China
                Author notes

                Edited by: Cynthia Aristei, University of Perugia, Italy

                Reviewed by: Paramita Dasgupta, Cancer Council Queensland, Australia; Angel Montero, HM Madrid Hospital, Spain

                *Correspondence: Jianbo Liu, drliujianbo@ 123456163.com

                This article was submitted to Breast Cancer, a section of the journal Frontiers in Oncology

                Article
                10.3389/fonc.2022.1032063
                9846313
                36686746
                0f03f6ba-7aab-40cc-8a0c-2313f99a25ca
                Copyright © 2023 Ke, Wang, Li, Feng, Yan and Liu

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 30 August 2022
                : 29 November 2022
                Page count
                Figures: 2, Tables: 3, Equations: 0, References: 59, Pages: 11, Words: 4447
                Categories
                Oncology
                Original Research

                Oncology & Radiotherapy
                breast cancer,recurrence,cancer-specific survival,competing risk,propensity score weighting,seer

                Comments

                Comment on this article